Tag: health economics

NANCY BERG NAMED ONE OF 2016 PM360 ELITE 100

ISPOR CEO Honored as a Transformational Leader  Princeton, NJ—June 6, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that CEO and Executive Director Nancy Berg has been recognized as a transformational leader by PM360’s annual ELITE award

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING WORKSHOP EXAMINES METHODOLOGIES FOR EVALUATING GEOSPATIAL ACCESS

Washington, DC—May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Workshop 23—Methodologies for Evaluating Geospatial Access in Medication Use Studies—was held this afternoon in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

PLENARY 3 OF ISPOR 21ST ANNUAL INTERNATIONAL MEETING EXPLORES REGULATORY AND LEGISLATIVE ISSUES IN HEALTH OUTCOMES RESEARCH

Washington, DC —May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) third plenary session for the Society’s 21st Annual International Meeting—Contemporary Regulatory and Legislative Issues in Health Outcomes Research—was held this morning in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL EXPLORES PATIENT PERSPECTIVES OF VALUE ASSESSMENT FRAMEWORKS IN ONCOLOGY

Washington, DC—May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 20—What Is the Value of Frameworks to Patients? The Case in Oncology—was held this morning in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL FOCUSES ON PRECISION MEDICINE AND ITS IMPACT ON OUTCOMES RESEARCH

Washington, DC—May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 18—Precision Medicine: The End of Outcomes Research?—was held this morning in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING WORKSHOP EXPLORES HOW TO MAKE PATIENTS AS PARTNERS IN RESEARCH A REALITY

Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Workshop 13—Patients as Partners in Research—Making It a Reality—was held this afternoon in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS MCDA AS A POSSIBLE NEW PARADIGM IN HEALTH CARE DECISION MAKING

Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

PLENARY 2 OF ISPOR 21ST ANNUAL INTERNATIONAL MEETING FOCUSES ON IMPACT OF BEHAVIORAL ECONOMIC MODELS ON MEDICAL DECISION MAKING

Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) second plenary session on Making Medical Decisions in an Irrational World  was held this morning at  the Society’s 21st Annual International Meeting in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING WORKSHOP EXPLORES RISK-SHARING AGREEMENTS

Washington, DC—May 23, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Workshop 2—Risk-Sharing Agreements for Manufacturers and Commercial Payers in the United States: How Can Theory Help Practice? Design and Aligning Incentives Are Key—was held

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS THE USE OF REAL-WORLD EVIDENCE IN HEALTH CARE DECISION MAKING

Washington, DC—May 23, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 5—Use of Real-Word Evidence in Payer Decision Making: Fact or Fiction?—was held this morning in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , ,